149 results
Page 2 of 8
8-K
EX-99.1
v2csutq zgz3mjs
3 Aug 23
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
7:05am
8-K
EX-99.1
42jwz8
15 May 23
OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023
7:05am
8-K
EX-99.1
3trv 2qezp
14 Nov 22
Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:10am
8-K
EX-5.1
xwokwkzge vi89t
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-10.1
fx3qh0nh6o4
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-1.1
vrc6kw4z
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
424B5
t62w7esbm6f78mvqs7l
6 Oct 22
Prospectus supplement for primary offering
4:12pm
S-8
EX-5.1
iopn6xmkghl77lmtfklp
4 Aug 22
Registration of securities for employees
7:40am
8-K
EX-99.1
5cv25v3
4 Aug 22
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:05am
8-K
EX-99.1
m6pnv2bfl8hz93 lz
12 May 22
Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
7:05am